Atlas Trials

Blood Brain Barrier Penetration and Pharmacokinetics of the Elemene in Malignant Patients.

Clinical trial NCT01679847 · UNKNOWN

Trial details

NCT number
NCT01679847
Sponsor
Dalian Holley Kingkong Pharmaceutical Co., Ltd
Status
UNKNOWN
Study type
OBSERVATIONAL
Cancer
Start date
2012-09-01
Primary completion
2013-04-01
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.